北京招聘

Primary Function:

Build scientific partnerships Phase II forward with healthcare professionals and decision makers to build advocacy. Strategically prepare and support the development, launch and commercialization of drug products through education of KOLs/Key Stakeholders, education of the scientific community and KOLs, clinical trial support, and by the scientific exchange seeking external insight to shape Zai Lab commercial and development programs. Compliance with applicable policies, procedures and other regulations.

Qualifications:

1. Education: Required: strong scientific merit – must be perceived as a peer by the customer base; MD, PharmD., pharmacist, PhD, advanced degree in medical or other life sciences with Oncology medical/technical background and proven competencies including communication, presentation, and negotiating skills, clinical research insight, business and market knowledge.

2. Languages: Native language (Chinese) and English (mandatory).

3. Experience: Proven ability to develop and foster peer-to-peer, requirement: credible relationships in order to educate and negotiate KOL/decision makers.

1). Working knowledge of the Healthcare System and of the research procedures as well as the ICH guidelines, GCP and other ethical guidelines relevant to the pharmaceutical industry.

2). Thorough knowledge of clinical medicine, disease management, and medical research in at least one therapeutic area.

3). Ability to synthesize recent scientific information, analyze them within strategic and regulatory settings.

4). Proven ability to use IT tools and interface effectively with a variety of technical platforms.

5). Strong personal integrity, and customer focus.

6). Excellent interpersonal communication, negotiation and advanced presentation skills.

7). Effectively contribute to work on multifunctional teams.

8). Must be able to adapt, organize, prioritize, and work effectively in a constantly changing field-based environment.

Zai Lab is an innovative biopharmaceutical company based in Zhang Jiang, Shanghai focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Zai Lab focus on innovation to meets the unmet medical needs. Zai has built up a strong pipeline with multiple programs on clinical stages. Zai Lab successfully listed on Nasdaq in Sep. 2017.

再鼎医药是一家总部设立于上海张江，致力于研究、开发和销售创新药物的制药企业。再鼎医药针对目前尚无良好治疗手段的疾病领域开发新药，在肿瘤、抗感染、自身免疫等方面建立了全面的产品线，服务中国和全球病患。再鼎医药于2017年9月在美国纳斯达克成功上市。